HIGHLIGHTS
- who: Xiaochang Ma from the Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China, Graduate School, China Academy of of Chinese Medicine, Beijing, China, Clinical Research Center for Chinese Medicine Cardiology, Beijing, China have published the research: Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology, in the Journal: (JOURNAL)
- future: These key targets and pathways will provide new ideas for future studies on the pharmacological mechanisms of cardiorenal protection by SGLT2 inhibitors. Rap1 is required to form a podocyte slit diaphragm a specialized junction universally injured in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.